BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31386166)

  • 1. Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults.
    Gabeff R; Boccara O; Soupre V; Lorette G; Bodemer C; Herbreteau D; Tavernier E; Maruani A
    Acta Derm Venereol; 2019 Nov; 99(12):1105-1109. PubMed ID: 31386166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Complex Arteriovenous Malformations Using a Novel Combination Therapeutic Algorithm.
    Chelliah MP; Do HM; Zinn Z; Patel V; Jeng M; Khosla RK; Truong MT; Marqueling A; Teng JMC
    JAMA Dermatol; 2018 Nov; 154(11):1316-1319. PubMed ID: 30326494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
    Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
    Sandbank S; Molho-Pessach V; Farkas A; Barzilai A; Greenberger S
    Acta Derm Venereol; 2019 Oct; 99(11):990-996. PubMed ID: 31304557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child.
    Burrows PE; Mulliken JB; Fishman SJ; Klement GL; Folkman J
    J Craniofac Surg; 2009 Mar; 20 Suppl 1():597-602. PubMed ID: 19293678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations.
    Kitagawa A; Yamamoto T; Matsunaga N; Yamaji M; Ikeda S; Izumi Y; Hagihara M; Ota T; Ishiguchi T
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):856-866. PubMed ID: 29417264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations.
    Timor-Tritsch IE; Haynes MC; Monteagudo A; Khatib N; Kovács S
    Am J Obstet Gynecol; 2016 Jun; 214(6):731.e1-731.e10. PubMed ID: 26873276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations.
    Jubeli E; Yagoubi N; Pascale F; Bédouet L; Slimani K; Labarre D; Saint-Maurice JP; Laurent A; Moine L
    Eur J Pharm Biopharm; 2015 Oct; 96():396-408. PubMed ID: 26386355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review.
    Nadal M; Giraudeau B; Tavernier E; Jonville-Bera AP; Lorette G; Maruani A
    Acta Derm Venereol; 2016 May; 96(4):448-52. PubMed ID: 26607948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriovenous malformations of the head and neck: natural history and management.
    Kohout MP; Hansen M; Pribaz JJ; Mulliken JB
    Plast Reconstr Surg; 1998 Sep; 102(3):643-54. PubMed ID: 9727427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus experience in adult patients with vascular malformations.
    Akyildiz A; Ismayilov R; Guven DC; Yildirim HC; Tatar OD; Kus F; Chalabiyev E; Turker FA; Dizdar O; Yalcin S; Gullu HI
    Vascular; 2024 Mar; ():17085381241241853. PubMed ID: 38523367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations.
    Colletti G; Dalmonte P; Moneghini L; Ferrari D; Allevi F
    Med Hypotheses; 2015 Sep; 85(3):298-302. PubMed ID: 26049824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLAPO syndrome: Effective response to treatment with oral rapamycin.
    González-Hermosa MR; Guerra E; Tuduri I; Vicente I; López-Almaraz R
    Dermatol Ther; 2019 Jul; 32(4):e12991. PubMed ID: 31172613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
    Durán-Romero AJ; Hernández-Rodríguez JC; Ortiz-Álvarez J; Domínguez-Cruz JJ; Monserrat-García MT; Conejo-Mir Sánchez J; Bernabeu-Wittel J
    Clin Exp Dermatol; 2022 Jan; 47(1):57-62. PubMed ID: 34240451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventional management of high-flow craniofacial vascular malformations: a database analysis and review of the literature.
    Dabus G; Linfante I; Benenati J; Perlyn CA; Martínez-Galdámez M
    J Neurointerv Surg; 2017 Jan; 9(1):92-96. PubMed ID: 27029395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.